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Protein deliveryFor cell penetrating peptides (CPPs) to fulﬁl their promise as effective delivery vectors we need a better under-
standing of their mechanisms of cell binding and uptake. This is especially the case when they are linked to dif-
ferent types of cargo. Here we describe new studies based on our previous ﬁndings suggesting that, for peptide-
CPP chimeras, distal hydrophobic residues upstream of the CPP sequence can have profound effects on the way
they interact with cells. We studied peptides bearing an N-terminal Glycine or Phenylalanine linked via a neutral
and ﬂexible bridging group, SGSGSGSG, to three well-studied CPPs: octaarginine, penetratin and TP10. Using a
combination of ﬂow cytometry, live-cell imaging and image analysis we examined the effects of this single
amino acid change on binding and uptake of Alexa488-ﬂuorophore, bovine serum albumin and quantum dot
cargoes. The inﬂuence of the glycine–phenylalanine switch for ﬂuorophore delivery was most dramatic in
TP10, increasing cellular uptake by 4.4 and 9.9 fold in non-adherent and adherent cells, respectively. Only
penetratin showedeffective uptakeof bovine serumalbuminwith thephenylalanine variant showing an increase
of 1.6 fold over the glycine variant. The uptake of quantum dots was most efﬁciently demonstrated by
octaarginine, with the glycine variant increasing uptake 4.8 fold and the phenylalanine variant increasing uptake
9.5 fold over quantum dots alone. Overall the data demonstrate that hydrophobicity distal to the CPP could be
utilised to enhance their capacity to bind to the cell membrane and deliver a range of macromolecules to the in-
sides of cells.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Cell penetrating peptides (CPPs) have been extensively explored as
potential deliverymechanisms for biopharmaceuticals such as peptides,
proteins or nucleic acids (reviewed here [1]). Cargo can be associated
with CPPs via different mechanisms for example through extension of
the CPP sequence at the N or C-terminus, through a chemical link to a
side chain such as cysteine, or the CPPs can associate via an ionic or hy-
drophobic interaction with a cargo. For highly charged cationic CPPs
such as R8 and Tat there is also clear evidence that they bind with
serum proteins which can affect both their stability and internalisation
capacity [2]. Via a similarmechanismCPPs can be utilised to bind to spe-
ciﬁc proteins to deliver them into different cell types [3]. This has signif-
icant potential in the delivery of biopharmaceuticals, and has expandedy and Pharmaceutical Sciences,
3NB, Wales, UK. Tel.: +44
. This is an open access article under
stal phenylalanine modiﬁcati
elease (2014), http://dx.doi.ointo in vivo studies with one notable example being the CPP penetratin
being explored as a potential delivery mechanism for insulin [4].
CPPs have also been shown to deliver a range ofmetallic nanoparticles
(NPs) into cells [5]. Quantumdots (Qdots) are small, ~10–25 nm, ﬂuores-
cent nanocrystals that have received much attention due to their unique
spectral and chemical characteristics. Qdots offer many advantages over
standard ﬂuorescent proteins and small molecules especially with re-
spects to their attractive luminosity and photostability properties that
allow for long-term visualisation of cellular structures and events, with
the potential to discriminate individual particles for single particle track-
ing experiments [6–8]. Accordingly, Qdots are increasingly deployed as
intracellular live-cell probes and are also expected to ﬁnd use in medical
diagnostics for example as contrast agents. Recently a cysteine–histidine
rich nona-arginine peptide (C-5H-R9-5H-C) was designed with the aim
of enhancingQdot uptake throughmodiﬁcation of thenet hydrophobicity
of the peptide to promote membrane association [9]. Although the pep-
tide enhanced Qdot uptake at high nanoparticle concentrations
(100 nM Qdots complexed with 6 μM peptide) over R9 alone or Pas
(FFLIP) modiﬁed R9, a direct translocation of the complex through the
plasmamembrane was cited as the major route of entry due to the accu-
mulation of material within cells at 4 °C [9].the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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CPP sequences have been extensively studied with respect to their in-
teractionwith cells and cellular uptake.Modiﬁcations in residueswithin
the CPP at single amino acid level have been demonstrated to signiﬁ-
cantly affect cell uptake, however, much less attention has been given
to the effect the cargo may have on CPP delivery capacity [10]. The
same can be said for relatively small cargo such as short peptide se-
quences. Indeed, a particularly attractive goal in drug delivery research,
targeting a number of diseases, is to identify a CPP that could deliver a
therapeutic peptide, either by direct plasma membrane translocation,
or endocytosis to the interior of the cell to speciﬁcally interfere with a
protein–protein interaction to modify cellular physiology. There is a
wealth of CPP literature on this subject but very few have directed re-
search effort to cargo effects. Recently we discovered that a single hy-
drophobic residue change (Ala/Phe) at the N-terminus of a 9-residue
cargo sequence had a dramatic effect on the cellular interaction and
the mechanism of cell death of the Bcl-2 converter peptide D-NuBCP-
9-r8 (fsrslhsllG-Ahx-rrrrrrrr) [11].
Here we extend on these ﬁndings to study the effects of exchanging
a single Gly residue to a Phe at the N-terminus of a commonly utilised
hydrophilic linker [12] (GSGSGSGSG) versus (FSGSGSGSG) attached at
the N-terminal end of well-characterised CPPs, octaarginine, TP10 and
penetratin. We demonstrate that this single residue change has, in
some cases, striking effects on CPP cell binding and capacity to deliver
ﬂuorophores, proteins and Qdots into cells.
2. Materials and methods
2.1. Materials
Cell culture media, serum, trypsin, Hoechst 33342, Alexa Fluor 488
C5-maleimide, bovine serum albumin (BSA)–Alexa647, 10 kDa dex-
tran–Alexa647 and Qdots (Qdot® 655 ITK™ Amino (PEG)) were pur-
chased from Life Technologies (Paisley, UK). Heparin sulphate,
Concanavalin A-FITC and sodium HEPES were purchased from Sigma
Aldrich (Gillingham, UK).
2.2. Cell culture
HeLa, human cervical carcinoma, cells (EMBL, Heidelberg,
Germany) were maintained in a humidiﬁed 5% CO2 37 °C incubator
as a subconﬂuent monolayer in DMEM supplemented with 10%
foetal bovine serum. Human acute myeloid leukaemia KG1a cells
(ECACC, Porton Down, UK) were maintained at a conﬂuency of be-
tween 0.5 and 2 × 106 cells/mL in RPMI 1640 medium supplemented
with 10% foetal bovine serum.
2.3. Peptide labelling
All peptides were purchased, unlabelled, from EZBiolabs, Carmel
USA (listed in Table 1) and labelled using Alexa 488 maleimide based
on minor modiﬁcations of a previously described method [13]. Brieﬂy,
peptides were dissolved in methanol at a concentration of 2 mg/mLTable 1.
Names and sequences of the peptides used in this study. All peptides use L-amino acids, bold le
and cell penetrating peptide sequences are underlined. Net charge, hydrophobicity and pI wer
Peptide Sequence
F(SG)4R8 Ac-FSGSGSGSGRRRRRRRRGC-NH2
G(SG)4R8 Ac-GSGSGSGSGRRRRRRRRGC-NH2
F(SG)4Pen Ac-FSGSGSGSGRQIKIWFQNRRMKWKKGC-NH2
G(SG)4Pen Ac-GSGSGSGSGRQIKIWFQNRRMKWKKGC-NH2
F(SG)4TP10 Ac-FSGSGSGSGAGYLLGKINLKALAALAKKILGC-NH2
G(SG)4TP10 Ac-GSGSGSGSGAGYLLGKINLKALAALAKKILGC-NH2
cRGD cyclo (RGDfK)
Please cite this article as: E.J. Sayers, et al., Distal phenylalanine modiﬁcati
tum dots by cell penetrating p..., J. Control. Release (2014), http://dx.doi.oand reacted with Alexa 488 C5-maleimide (also dissolved in methanol
to 2 mg/mL) at a molar ratio of 1.1 to 1 peptide/ﬂuorophore for 3 h at
room temperature. Labelled peptides and reactants were separated
using reverse phase HPLC on a C18 Luna 100 Å 5-μm semipreparative
column (Phenomenex, Macclesﬁeld, UK) with the labelled peptide col-
lected and freeze-dried. Labelling and conjugatemasswas conﬁrmed by
matrix-assisted laser-desorption ionisation–time-of-ﬂight spectrome-
try and quantiﬁed byUV spectrometry. All labelled peptideswere resus-
pended to a stock concentration of 1 mM in autoclaved distilled water,
aliquoted and frozen at−80 °C until needed.
2.4. Flow cytometry analysis
HeLa cells were seeded at a density of 1 × 105 cells per well the day
before the experiment in a 12-well plate. On the day, cells were incubat-
edwith 2 or 5 μMlabelled peptide in completemedium for 1 h in a 37 °C
5% CO2 incubator before trypsination in 0.05% Trypsin–EDTA for 5 min.
KG1a cells were seeded into a 12-well plate at a density of 2 × 105 cells
per well and incubated with 2 or 5 μM of labelled peptide in complete
medium for 1 h in a 37 °C 5% CO2 incubator. Both trypsinised HeLa cells
and suspension KG1a cells were washed by centrifugation (800 ×g for
2 min) at 4 °C in ice cold PBS before washing in ice cold 140 μg/mL
heparin sulphate in PBS to remove surface bound peptide and washed
a further three times in ice cold PBS. Samples were analysed on a Becton
Dickinson FACSCalibur analyser, gated using forward and side scatter
with 1 x 104 viable cells analysed. Statistical signiﬁcance was tested
using a one-way ANOVA test.
2.5. Cell binding and uptake analysis using confocal microscopy
HeLa cells were seeded at a density of 2.5 × 105 cells per imaging
dish (MatTek, Ashland, US) and allowed to adhere overnight under tis-
sue culture conditions. On the day of experiment, cells were incubated
with 2 or 5 μM labelled peptide and incubated for 1 h, 37 °C 5% CO2.
Cells were washed in PBS followed by 140 μg/mL heparin sulphate in
PBS andﬁnally imaged in imagingmedium(phenol red free DMEMsup-
plementedwith 10% FBS and 20mMHEPES) on a Leica SP5 confocalmi-
croscope (63× 1.4 NA objective using a 488 nm laser with a 95.5 μm
pinhole, pixel size is 283 nm, using Leica Type F immersion oil).
KG1a cells were incubated in 200 μL complete medium containing
either 2 or 5 μM labelled peptide at a density of 1 × 105 cells per well
for 1 h under tissue culture conditions. Cells were washed in PBS and
heparin followed by centrifugation (as for ﬂow cytometry above) and
immediately imaged in imagingmediumas above. Microscopy and pro-
cessing settings were kept consistent within each set of CPPs.
2.6. Pulse chase analysis of F-/G-(SG)4TP10-Alexa488
In a 35 mm imaging dish 1.75 × 105 cells were seeded in complete
medium and allowed to adhere overnight in a 37 °C incubator. On the
morning of the experiment 200 μg/mL 10 kDa dextran–Alexa647 was
pulsed into the cells for 2 h in complete medium before washing and
allowed to internalise by chasing for a further 4 h in complete medium.tters denote the changed hydrophobic - neutral amino acid, D-amino acids are lower case
e calculated using Biosynthesis’ Peptide Properties calculator.
Net charge
(pH 7)
Hydrophobicity
(pH 6.8)
pI
7.91 0.74 13.53
7.91 −4.37 13.53
6.91 18.3 12.83
6.91 14.7 12.83
3.91 33.09 10.66
3.91 30.06 10.66
on for enhancing cellular delivery of ﬂuorophores, proteins and quan-
rg/10.1016/j.jconrel.2014.07.055
3E.J. Sayers et al. / Journal of Controlled Release xxx (2014) xxx–xxxCells were loaded with 2 μM F-/G-(SG)4TP10-Alexa488 for 1 h in com-
plete medium before washing and imaging on the confocal microscope
as previously described, using the 488 nm and 633 nm lasers. The
cells were subsequently returned to the 37 °C incubator before imaging
24h after initial incubationwith the peptide on the confocalmicroscope
as previously described. For colocalization analysis individual cells were
selected according to their DIC proﬁle and analysed to obtain the mean
unthresholded Pearson's coefﬁcient per cell using the ImageJ plugin
Coloc 2 for an average of 31 cells ± 3 for each experiment condition.2.7. Peptide complexation with BSA–Alexa647
HeLa cells were seeded at a density of 2.5 × 105 cells per imaging
dish and allowed to adhere overnight under tissue culture conditions.
Separately, 2 μM, 500 nM or 100 nM of unlabelled peptide or peptide
diluent control was incubated for 30 min with 2 μg/mL, 500 ng/mL or
100 ng/mL BSA–Alexa647 respectively in autoclaved distilled 0.2 μm
ﬁltered water in a ﬁnal volume of 50 μL at 37 °C. To this, 150 μL of com-
plete medium was added and incubated with the cells for 1 h, 37 °C 5%
CO2. Cells were washed and imaged in imaging media (supplemented
for the ﬁnal 10 min with 10 μg/mL Hoechst 33342) as described with
microscopy settings remaining constant for all images for comparative
CPP uptake analysis.2.8. Peptide complexation with Qdots
For gel electrophoresis, 25 nM Qdots were complexed with 0.25 μM
to 250 μM peptide for 30 min in PBS at room temperature. Products
were assessed by gel electrophoresis on horizontal 0.8% agarose gels
using TAE pH 8.0 running buffer. Sample (10 μL) was loaded with 3 μL
30% glycerol in running buffer and run for 1 h under a steady current
and 100 V (4 V per 1 cm of gel).2.9. Live-cell imaging of Qdot uptake
Qdot and peptide stocks were prepared separately at 100× in PBS
before combining in serum free DMEM for 30 min at RT and adding to
cells at 37 °C. HeLa cells were seeded at 1 × 104 cells per cm2 in 96
well black walled plastic dishes (Greiner μclear Bio One, Stonehouse,
UK), or glass coverslips and grown for 48 h in complete media. Cells
were treated for 1 h in serum free DMEM before counterstaining with
25 μg/mL Concanavalin A-FITC (ConA) for 5 min in serum free DMEM
to label the plasma membrane. ConA treated cells were then washed a
further 3× in fully supplemented DMEM before immediate analysis as
live cells by wide-ﬁeld ﬂuorescence microscopy or following a further
24 h incubation in complete media under tissue culture conditions.
Cells were imaged using an Olympus (London, UK) wide-ﬁeld imaging
system (Olympus 20× 0.75 NA lens).Fig. 1. Flow cytometry analysis of the uptake of 2 or 5 μM Alexa488 labelled peptide into
HeLa and KG1a cells. Graphs represent the increase in ﬂuorescent intensity in response
to the cellular uptake of either 2 μM (a and c) or 5 μM (b and d) of the peptides F(SG)4 -
R8/-TP10/-Pen-Alexa488 relative to the uptake of G(SG)4 -R8/-TP10/-Pen-Alexa488 re-
spectively. Uptake was measured after 1 h at 37 °C in complete medium in KG1a (a-b)
or HeLa (c-d) cells and analysed byﬂowcytometry. Fluorescence intensity data is calculat-
ed using the geometric mean following three independent experiments performed in du-
plicate, error bars represent standard error. * p b 0.05, ** p b 0.005. Sample Histograms are
included as Supplementary Figure 1.2.10. Quantiﬁcation of Qdot uptake and colocalization analysis
Using ImageJ [14] an average of 66 individual cells (minimum of 51)
were segmented based on ConA cell-surface stain proﬁles and analysed.
A rolling ball background subtractionwas performed (radius= 50) and
untreated cells were used as baseline. Apoptotic and dividing cells iden-
tiﬁed by distinct morphological characteristics such as cellular blebs or
the occurrence of a pair of rounded cells in close contact were discarded
from analysis. For Qdot uptake analysis, the integrated intensity per cell
was quantiﬁed per treatment condition. For colocalisation analysis indi-
vidual cells were analysed to obtain the mean Pearson's coefﬁcient per
cell using the ImageJ plugin Coloc 2.
Tests for statistical equality were performed using a two tailed t-test
assuming unequal variance.Please cite this article as: E.J. Sayers, et al., Distal phenylalanine modiﬁcati
tum dots by cell penetrating p..., J. Control. Release (2014), http://dx.doi.o3. Results and discussion
3.1. Fluorophore as CPP cargo
We have previously shown that a single N-terminal amino acid
modiﬁcation, spaced nine residues from the CPP octaarginine, from
alanine to phenylalanine had a dramatic effect on its interaction
with and uptake into cells [11]. It was therefore of interest to inves-
tigate what effect a single phenylalanine change distal to the CPP
sequence would have on well-characterised CPPs octaarginine,
penetratin and TP10 (Table 1) using a membrane impermeable
sequence (SG)4 that is frequently used as a bridging sequence in
protein research [15].
After analysis by ﬂow cytometry, KG1a cells showed a small but sig-
niﬁcant increase in uptake of octaarginine peptides F(SG)4R8-Alexa488
over G(SG)4R8-Alexa488 at 2 μM, while HeLa cells showed no signiﬁ-
cant change at this concentration (Fig. 1a and c). At 5 μM both cell
types showed a small but signiﬁcant increase in cell uptake of the Phe
peptide over the Gly peptide (Fig. 1b and d). By microscopy, the differ-
ence in uptake is not as clearly visible at either concentration with the
exception of KG1a at 5 μM where some cells show cytosolic labelling
in addition to the punctate labelling seen at the lower concentration
(Fig. 2). We have previously shown there is a similarly heterogeneous
population of cytosolic and punctate labelling in KG1a cells when incu-
bated with 5 μM R8-Alexa488 [16] indicating the capacity to enter the
cytosol is not likely due to the phenylalanine alone.
Both penetratin and TP10 contain hydrophobic residues in their se-
quence to differing degrees (Table 1). Penetratin is classiﬁed as a cation-
ic peptide, due to the high number of lysine and arginine amino acids
present within its sequence, but also contains the hydrophobic amino
acids isoleucine and phenylalanine [10]. TP10 is classiﬁed as an amphi-
pathic CPP, it naturally forms into a helical structure displaying cationic
residues on one side of the helix and hydrophobic residues on the other.
These are likely to interact with cells in a different way compared to
purely cationic CPPs and we investigated this further with the same
cargo sequences.
Penetratin showed a N100% increase in the uptake of F(SG)4Pen-
Alexa488 over G(SG)4Pen-Alexa488 in HeLa cells at both 2 (119%) and
5 μM (164%) concentrations (Fig. 1c and d). Whilst in KG1a cells there
was a signiﬁcant increase at 5 μM with a small but non-signiﬁcant in-
crease at 2 μM (Fig. 1a and b). The inﬂuence of the Gly–Phe switch inon for enhancing cellular delivery of ﬂuorophores, proteins and quan-
rg/10.1016/j.jconrel.2014.07.055
Fig. 2. Uptake of Alexa488 labelled peptides into HeLa and KG1a cells at 2 or 5 μM after 1 h incubation in complete medium. Peptides, F-/G- (SG)4R8-Alexa488 (a, d), F-/G- (SG)4TP10-
Alexa488 (b, e) or F-/G- (SG)4TP10-Alexa488 (c, f) at either 2 or 5 μMwere incubated in complete medium for 1 h at 37 °C with HeLa (a-c) or KG1a (d-f) cells and imaged immediately
by confocal microscopy. Images represent either a single section through the cell at themid-point of the nucleus, ormaximumprojections of thewhole cell. Scale bar= 20 μm (HeLa, a-c)
or 10 μm (KG1a, d-f).
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(Fig. 1). A likely reason for this considerable increase in HeLa cell ﬂuo-
rescence (~800%) was discovered when peptide uptake was viewed
via microscopy that revealed extensive F(SG)4TP10-Alexa488 labelling
of the plasmamembrane that could account for this signiﬁcant increase
in cell associated ﬂuorescence (Fig. 2). This membrane bound peptide
did not, however, account for the total increase in signal as single sec-
tion images also identiﬁed intracellular punctate structures indicating
endocytosis. The ﬂuorescence intensity of these structures were appre-
ciably greater in the Phe over the Gly variant. Quantiﬁcation of ﬂuores-
cence uptake images of the TP10-Alexa488 variants conﬁrms this with
whole cell, membrane and intracellular ﬂuorescence proﬁles all higher
in the Phe variant over the Gly control (Supplementary Fig. 2), despite
a large proportion of the peptide found on the plasma membrane.
After further incubation of these cells in the absence of additional pep-
tide addition this membrane fraction was signiﬁcantly depleted
(Fig. 3). Colocalisation analysis demonstrated that a large proportion
of both the Phe and Gly variants of TP10 after this chase period
colocalised with lysosomal dextran (Pearson's coefﬁcient of 0.85 ±
0.07 and 0.72 ± 0.08 respectively). This value is signiﬁcantly higher
than that observed after 1 h where the vast majority of the peptide
label is conﬁned to the plasma membrane (0.42 ± 0.08 and 0.47 ±
0.09 respectively). Quantiﬁcation of the amount of total cell associated
ﬂuorescence at the end of the chase period indicates that the majority
of the initial membrane associated ﬂuorescence is internalised to lyso-
somes via membrane turnover. Interestingly, there was little evidencePlease cite this article as: E.J. Sayers, et al., Distal phenylalanine modiﬁcati
tum dots by cell penetrating p..., J. Control. Release (2014), http://dx.doi.oof plasma membrane bound G(SG)4TP10-Alexa488 or F(SG)4TP10-
Alexa488 in KG1a cells after identical one hour incubations (Fig. 2e)
but revealed a much higher level of ﬂuorescence for cells treated with
the F variant, with 5 μM peptide incubations resulting in some degree
of cytosolic labelling.
Microscopy analysis revealed distinct punctate structures when
visualising penetratin variants, with a clear increase in uptake of the Phe
over the Gly form at 5 μM in HeLa cells (Fig. 2) reﬂecting the change
seen in the FACS data (Fig. 1). This difference is more difﬁcult to visualise
inKG1a cellswith both formsof thepeptide showing clear punctate struc-
tures and at 5 μM both peptides demonstrating cytoplasmic labelling.
A number of studies have shown that direct hydrophobic modiﬁca-
tions of CPPs show improved abilities to internalise into cells. A Phe-
Phe addition to the N-terminus of octaarginine has been shown to
greatly increase its internalisation, with the longer F4 sequence increas-
ing this further [17]. PasR8, which has the hydrophobic FFLIP sequence
at the N-terminus of octaarginine, also aids octaarginine internalisation
[18]. Increasing distal hydrophobicity via the Gly/Phe mechanism
described had positive effects but these were modest for R8 compared
with the other two CPPs. Our data therefore suggests that hydrophobic-
ity within the CPP itself is an important parameter for enhancing uptake
via this mechanism (Table 1). Penetratin requires the presence of a cen-
tral tryptophan formembrane translocation [4], this residue is frequent-
ly found at the membrane–water interface in transmembrane proteins
[19]. If the phenylalanine itself aids in membrane association it would
be interesting to determine whether the effects of phenylalanine canon for enhancing cellular delivery of ﬂuorophores, proteins and quan-
rg/10.1016/j.jconrel.2014.07.055
Fig. 3. Uptake and 24 h internalisation of F-/G- (SG)4TP10-Alexa488 into HeLa cells. HeLa
cells were incubated with 2 μM F- or G- (SG)4TP10-Alexa488 for 1 h before washing and
imaging in complete imaging medium, the cells were then returned to the incubator
and imaged after 24 h. (a) Images represent a single section taken on the confocal micro-
scope of peptide (green) and pulse-chased dextran (red) with colocalisation as yellow.
Scale bar = 20 μm. Images were quantiﬁed for cell associated G- or F- (SG)4TP10-
Alexa488. (b) Data represents the mean ﬂuorescence intensity per cell of an average of
24 ± 4 cells, error bars represent ± SD.
5E.J. Sayers et al. / Journal of Controlled Release xxx (2014) xxx–xxxbe enhanced by Trp or whether these two amino acids together could
have synergistic effects with respect to cell binding and translocation
to the insides of cells.
3.2. Protein as CPP cargo
Penetratin, HIV-Tat, and transportan have previously been shown to
be able to deliver BSA as non-covalent complexes into a range of cell
lines [3]. Both HIV-Tat and transportan are closely related to the pep-
tides used in this study, with the former being highly cationic, and
TP10 being a shorter derivative of transportan. Based on our studies
with a small ﬂuorophore as cargo (Figs. 1–2) we investigated by live
cell confocal microscopy, whether the Gly/Phe switch had any effect
on the capacity of these peptides to deliver BSA.
Internalisation of BSA alone was barely detectable in HeLa cells at
0.5 μg/mL and to visibly observe the uptake of this protein required
increasing the concentration to 25 μg/mL (Fig. 4). For TP10 and
penetratin complexes, with BSA at a ﬁnal concentration of 0.5 μg/mL
on cells both Gly and Phe variants increased uptake into distinct punc-
tate endosomal structures. Of these peptides F(SG)4Pen showed the
highest capacity to deliver BSA with an increase of 58% of the Phe overPlease cite this article as: E.J. Sayers, et al., Distal phenylalanine modiﬁcati
tum dots by cell penetrating p..., J. Control. Release (2014), http://dx.doi.othe Gly variant (Supplementary Fig. 3). Both TP10 variants were able
to deliver BSA into HeLa cells, however, the differences between
these two with respects to BSA delivery capacity was small with a
high degree of variance between cells. At lower complex concentra-
tions both penetratin and TP10 BSA complexes continued to inter-
nalise into punctate structures visible above the background
ﬂuorescence (Supplementary Fig. 4) although there is a degree of
variance between cells. There was no increase in the uptake of BSA
by the two R8 variants, compared to BSA alone. This may be due to
differences in BSA-complexation, cell interaction or stability. For all
peptides and concentrations studied here, using this microscopy
method, we could not detect diffuse BSA labelling over background
ﬂuorescence thus it remains to be determined whether any of the
CPPs deliver proteins into the cytosol.
Albumin has a pI of 4.7 making it negatively charged in water [20],
and CPP-peptides studied here all have a pI greater than 10 making
them positively charged in the same solution. The preformed
penetratin-/TP10-BSA complexes showed stability under the experi-
mental conditions used that allowed for cell entry via endocytosis. Of
note here is that all the peptides contain a free cysteine at the C-
terminus and this reactive amino acid could have also contributed to
aiding complexation to BSA and also plasma membrane binding [21].
3.3. Qdots as CPP cargo
Interaction of CPPs with anionic Qdots has been previously
documented [22,23] and is thought to reﬂect electrostatic interactions
between anionic groups on the nanoparticle surface, typically carboxyl
groups as found in many commercial QD preparations, and basic
arginines or lysines on the CPP. The speciﬁc display of a non-
covalently bound CPP on the surface of a Qdot is expected to be
critical in determining the interaction of the peptide with the
cell membrane, and there is considerable scope for engineering a
peptide which favourably interacts with both the nanoparticle and the
cell surface.
Here, we further explored utilising non-covalent binding of CPPs as a
paradigm for delivering anionic Qdots using our panel of Phe modiﬁed
peptides. To assess binding, CPPs were complexed with Qdots and
analysed by agarose gel electrophoresis. All CPPs used in this study
formed complexes with the Qdots demonstrated by a reversal of Qdot
migration, now towards the negative electrode (Fig. 5a). The migration
of the entire panel of CPP:Qdot complexes is shown in Supplementary
Fig. 5 and summarised in Fig. 5b. This is presented as the maximummi-
gration of Qdot:CPP complexes, against Qdot alone towards the positive
electrode. cRGD as a peptide with a small size and low net charge
showed no evidence of binding. At higher CPP concentrations Qdot
complexes progressively acquired a positive net charge, although for
some peptides, particle aggregation was apparent due to the streaking
of bands or the entrapment of material within the loading-well (Fig. 5,
Supplementary Fig. 5). Aggregation was most clearly observed in
G(SG)4TP10 treated Qdots which resulted in the formation of large ag-
gregates which failed to migrate into the gel matrix. F(SG)4TP10 and
Pen based peptides demonstrated streaking during migration implying
the formation of heterogeneous aggregates at higher peptide concentra-
tions. Particle aggregation is a critical parameter when preparing drug
delivery complexes due to the potential wide-ranging effects resulting
from this process [24,25]. Clear aggregation of Qdots when using
G(SG)4TP10 could result from a particular orientation of the peptide at
the Qdot surface which acts to destabilise the repulsive force between
adjacent particles and promote agglomeration through either ionic of
van der Waals modes [25]. For R8 based peptides, aggregation was not
evident by gel electrophoresis (Fig. 5a) allowing for further cell-based
analysis with these entities. Qdots by themselves demonstrated appre-
ciable levels of binding to HeLa cells following a 1 h exposure in serum
free media (Supplementary Fig. 6). Counterstaining with the lectin
ConA to label the plasma membrane at the end of the experimenton for enhancing cellular delivery of ﬂuorophores, proteins and quan-
rg/10.1016/j.jconrel.2014.07.055
Fig. 4. Internalisation of BSA-Alexa647 or BSA-Alexa647-CPP complexes inHeLa Cells. Complexes of 2 μg/mL of BSA-Alexa647with 2 μMF-/G-(SG)4-Penetratin/-R8/-TP10were allowed to
form for 30min at 37 °C before being diluted 1 in 4 in completemedia and incubatedwith cells for 1 h. Samples were immediately imaged on a confocalmicroscopewith greyscale images
showing BSA-Alexa 647 only and overlay images showing BSA-Alexa647 (red) and Hoechst 33342 (blue) as maximum (xyz) projections. Scale bar = 20 μm.
6 E.J. Sayers et al. / Journal of Controlled Release xxx (2014) xxx–xxxsuggested themajority of material was localised to this structure. Cellu-
lar labelling demonstrated a dose-dependent increase in integrated
ﬂuorescence intensity with increasing Qdot concentration. There was
considerable heterogeneity within the sample population with regardFig. 5. CPP-Qdot complex formation and Qdot uptake in cells. Gly and Phe R8 CPPs (a), and
peptides described in Table 1 (b), were assessed for Qdot binding by electrophoresis. Blue
lines indicate the position of loading wells. (a) Maximum migratory distance of Qdot
bands from the well centre towards the positive electrode was plotted for each peptide
and normalised to the Qdot only band. (b) Dotted lines in b indicate well positions in
which signs of Qdot aggregation were observed due to the retention of material within
the well.
Please cite this article as: E.J. Sayers, et al., Distal phenylalanine modiﬁcati
tum dots by cell penetrating p..., J. Control. Release (2014), http://dx.doi.oto extent of binding (Supplementary Fig. 6), manifest as larger than ex-
pected error bars.
In the presence of a ﬁxed concentration of 1 μM G(SG)4R8 or
F(SG)4R8, cellular binding of Qdots is increased at low and high nano-
particle concentrations (0.316 or 3.16 nM Qdots). In control cells the
majority of Qdots appear to localise evenly to the plasma membrane
and only a small fraction appear to be internalised in punctate vesicles
(Fig. 6a). Complexation of Qdots with Gly or Phe R8 greatly increased
Qdot cell binding, with enhanced labelling of both plasma membrane
and internal vesicular compartments.
Binding is quantiﬁed in Fig. 6b showing that both G(SG)4R8 and
F(SG)4R8 peptides enhance cellular binding of Qdots by roughly 4.8
fold and 9.5 fold respectively, over Qdots alone. Here the Phe modiﬁed
R8 demonstrated a signiﬁcant increase in the cell binding activity
when compared to the Gly-modiﬁed variant. The reasons for this
could reﬂect a direct interaction of the phenylalanine residue with cel-
lular surfaces, or a felicitous display of the peptide at the Qdot surface
which enhances cell association via the R8 motif. For penetratin and
TP10 Qdots, aggregationwas clearly evidentmaking data interpretation
problematic. Interestingly the aggregates were only visible on the
cell surfaces rather than on the tissue culture plastic (Supplementary
Fig. 7).
In light of such a large degree of cargo binding to the plasma mem-
brane we sought to investigate how the constant cycling of plasma
membrane components over an extended time frame might affect the
internalisation of this membrane associated Qdot fraction. To address
this question Qdot complexes were pulsed onto HeLa cells for 1 h
followed by a brief counterstain with ConA and a further 24 h recovery
(Fig. 6c). Quantiﬁcation of the integrated intensity per cell revealed that
the majority of Qdots at the lower concentration of 0.316 nMwere lost
during the incubation, with ﬂuorescent proﬁles only slightly above au-
toﬂuorescence (Fig. 6b, Supplementary Fig. 8). At 3.16 nM Qdots, con-
trol cells also showed little ﬂuorescence, whereas G- and F-(SG)4R8
Qdot complexes exhibited binding proﬁles which paralleled thoseon for enhancing cellular delivery of ﬂuorophores, proteins and quan-
rg/10.1016/j.jconrel.2014.07.055
Fig. 6. Phe R8 enhances Qdot cell uptake over Gly R8 andQdots alone. Qdots (red channel)
at 0.316 or 3.16 nM(a)were assayed in liveHeLa cells for 1 h following complexationwith
a ﬁxed concentration of 1 µMG(SG)4R8 or F(SG)4R8.ConA-FITC (green channel) was used
to label the cell surface allowing Qdot binding to be quantiﬁed in (b) by measuring the
mean integrated intensity per cell (RFU) in the Qdot channel. After initial loading of
Qdot and ConA, cells were reanalysed after a 24 h chase where Qdots redistributed to a
perinuclear compartment (c). * p b 0.05. Scale bar = 20 μm.
7E.J. Sayers et al. / Journal of Controlled Release xxx (2014) xxx–xxxrecorded after 0 h recovery, although with markedly reduced intensi-
ties. By measuring the mean integrated intensity per cell a direct com-
parison between the two time points was possible, revealing that the
Qdot ﬂuorescence remaining after 24 h for 3.16 nM G- and F-(SG)4R8
Qdot complexes stood at 17% and 26%, respectively (Fig. 6b). Again, a
signiﬁcantly larger Qdot proﬁle was retained in F-(SG)4R8 treated cells
when compared to cells incubated with G-(SG)4R8. In control cells the
majority of ConA was internalised into a perinuclear compartment
after 24 h, with Qdots alone showing a reasonable degree of
colocalisation with this probe (Pearson's colocalisation value 0.54 ±
0.17). Qdots complexed with Gly or Phe R8 however both showed a
striking colocalisation with ConA positive compartments that was
more pronounced in the case of Phe-R8 reﬂecting the increased Qdot
cell labelling using this peptide (Pearson's value 0.71 ± 0.16 and 0.79
± 0.12 for G- and F-(SG)4R8 respectively, Fig. 6c). F(SG)4R8 complexed
Qdots appeared to colocalise almost exclusively with ConA. This lectin
has recently received attention due its reported antitumor effects in a
variety of cell lines including ML-14a hepatoma [26,27] and MCF-7
breast carcinoma [28] lines. InML-14a cells, ConAwas trafﬁcked tomito-
chondria and lysosomes following a 3 h incubation triggering LC3-II
conversion and cell death [26]. The stainingwe observed here is consis-
tent with localisation of Qdots and ConA to endolysosomal compart-
ments, indicating Gly and Phe R8 peptides selectively target Qdots to
these organelles. As described previously for ﬂuorophore cargo
(Fig. 3), cell internalisation during this 24 h period may result primarily
as a consequence of plasmamembrane turnover opening the possibility
of a controlled cell uptake mechanism of nanoparticle, and other CPP
cargo, entry. The distribution ofmaterial here also bears a strong resem-
blance to staining by the commercially available Qdot cell label known
as Qtracker (Life Technologies) [29]. Qtracker is a labelling kit designed
for long-term cell tracking overmany generations, and utilises a custom
peptide to deliver material to the endolysosomal compartment. We
suggest that using non-covalent binding of R8 peptides to amine
Qdots may be a viable alternative for cell tracking experiments, and
opens the possibility of extending this method to other nanoparticles
of interest.Please cite this article as: E.J. Sayers, et al., Distal phenylalanine modiﬁcati
tum dots by cell penetrating p..., J. Control. Release (2014), http://dx.doi.o4. Conclusions
Here we have demonstrated the ability of a single Gly to Phe change
in the N-terminus of a neutral bridging sequence to have a dramatic
change in the uptake and delivery capacity of three different CPPs. In
some cases this signiﬁcantly enhances the vector properties of the
CPP. The universality of this strategy of adding a hydrophobic entity
downstream or possibly upstream of the CPP sequence remains to be
determined.
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